CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 58 enrolled
Drug / intervention
Nicotine lozenge +2 moredrug
Likely dose
Nicotine lozenge 4mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01654107
NCT01654107Phase 1Completed
CompareCT.gov

Persistence-Targeted Smoking Cessation

Rutgers, The State University of New Jersey·interventional·Posted Jul 31, 2012·Updated Aug 21, 2017

In Brief

A Phase 1 clinical trial evaluating Persistence Targeted Smoking Cessation, Clearing The Air, and 1 other intervention for Tobacco Use Disorder. Completed, enrolled 58 participants across 1 site.

Detailed Summary

The investigators propose to develop a theory-based smoking cessation intervention (called Persistence-targeted smoking cessation; PTSC). PTSC includes 8 weekly individual counseling sessions and use of nicotine lozenge for 12 weeks. The investigators will test the feasibility and preliminary efficacy of the intervention (i.e., cigarettes per day and prolonged abstinence).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Use Disorder
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Phase 1CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 31, 2012
Enrollment StartJul 1, 2012
Primary CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 13.9 years ago

Interventions

Persistence Targeted Smoking Cessationbehavioral

8-weeks of smoking cessation counseling ("Persistence Targeted Smoking Cessation")

Clearing The Airbehavioral

8-weeks counseling + 12-weeks nicotine lozenge based on NCI protocol, Clearing The Air

Nicotine lozengedrug

12-weeks 4mg nicotine lozenge